Companies›Fast Moving Consumer Goods›Fast Moving Consumer Goods›Personal Products
NSE:PGHH

P&G HYGIENE & HEALTH CARE

Fast Moving Consumer Goods › Personal Products·NIFTY SMALLCAP 500
₹6,809.00
at close · 27 Oct 2026
▼ 9.00 (-0.13%)

Latest filings

Next results: Thu, 12 Nov · Financial Results
  1. Submission of SEBI Regulation 74(5) Certificate for Q2 FY27 · Compliance
  2. Trading Window Closure Ahead of Q2 Results · Compliance
  3. Flavia Machado appointed as Company Secretary, effective Sep 29, 2026 · Management Changes
All filings ↓
Ask Nexa about P&G HYGIENE & HEALTH CARE

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Sells personal care products in India across two flagship brand families: feminine hygiene (Whisper) and health care (Vicks). Whisper leads India's feminine care category with nearly half the market, selling sanitary pads and period pants to women; the femcare category itself still has sub-50% consumer penetration, which management flags as a runway. Vicks holds more than 50% share in India's Cough & Cold category, selling products such as VapoRub, Cough Syrup, Steam Pods, Double Power drops and ZzzQuil sleep supplements to households. Distribution reach expanded by 1 million stores over three years, with e-commerce and quick commerce (including a Zepto co-creation for Whisper Period Pants) cited as key growth channels. The cost stack is dominated by other operating expenses at 31.2% of revenue and materials at 17.2%, with a productivity programme delivering Rs 93 cr of savings in FY25 and Rs 86 cr in FY26, fully reinvested into brand and product superiority. FY26 revenue stood at Rs 4,290.42 cr with an EBITDA margin of 28.28%.

Operating scale
Whisper share of feminine care market
Nearly 50%FY25
Vicks share of Cough & Cold category
>50%FY25
Feminine care category penetration in India
<50%FY25
Distribution reach expansion
1 million additional stores in 3 yearsFY25
Productivity savings
Rs 93 cr (FY25); Rs 86 cr (FY26)FY25 / FY26
FY26 revenue
Rs 4,290.42 crFY26
Who pays it
Indian retail consumers — women for Whisper feminine hygiene, households for Vicks cough, cold and sleep products, sold through general trade, modern retail, e-commerce and quick commerce.
Biggest cost
Other operating expenses (31.2% of revenue) and materials at 17.2% of revenue, with raw materials flagged as a swing factor in quarterly results.
Kind of business
Asset-light, brand-led personal care FMCG built around two category-leading franchises.
Where it sits
Category leader in Indian feminine care (~50% share via Whisper) and in Cough & Cold (>50% share via Vicks), with the broader femcare category still under 50% penetrated.
Market Cap
₹22,102 Cr
P / E (TTM)
27.9×
EV / EBITDA
19.3×
Div Yield
3.82%
Growth
9.0%▲
Revenue 5y CAGR
PAT +7.3% · EBITDA +7.4%
Quality
135.4%▲
ROCE (FY26)
ROE 113.7% · margin 28.3%
Leverage
0.00·
Debt / Equity · low
Net cash ₹557 Cr
Revenue FY21→FY26
1.5×▲
Margin −1.7 pts
₹2,788 Cr → ₹4,290 Cr
Moves on a normal day
0.69%·
Median daily move
Last 267 sessions · the yardstick for filing-day moves
Where it sits among 15 Personal Care peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#5/15
P/B#12/13
ROCE#1/16
ROE#1/13
Debt / Equity#1/13
EBITDA margin#8/13
Revenue growth#11/14
Profit growth#11/13

Scorecard

Measured from the filed financials, judged against its Personal Care peers · as of FY26 — not investment advice

Strengths
Returns on capital 135.4%
#1 of 16 in Personal Care on the latest reported figures
Negative working-capital cycle — the business is funded by its suppliers
Pays out 99% of profit as dividend
Concerns
Nothing flagged in the filed numbers.

Charts

How has the market priced it — with filings on the timeline?

PGHH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from P&G HYGIENE & HEALTH CARE's filed financials and exchange disclosures

What does P&G HYGIENE & HEALTH CARE do?

P&G HYGIENE & HEALTH CARE is a Personal Products company listed on NSE and BSE, trading under the symbol PGHH.

Is P&G HYGIENE & HEALTH CARE profitable?

Yes. Over the trailing twelve months P&G HYGIENE & HEALTH CARE reported a net profit of ₹791 Cr on revenue of ₹4,245 Cr.

Does P&G HYGIENE & HEALTH CARE pay a dividend?

Yes. The dividend yield is 3.82% at the current price. It paid out 99% of its profit as dividend in FY26.

Is P&G HYGIENE & HEALTH CARE debt-free?

Yes. It reported no borrowings on its 31 Mar 2026 balance sheet, and ₹557 Cr of cash.

Is P&G HYGIENE & HEALTH CARE expensive compared with its peers?

On trailing P/E, P&G HYGIENE & HEALTH CARE ranks 5 of 15 in Personal Care — cheaper than 71% of them, against an industry median of 35.7×. This is a position, not a valuation judgement.

How much does the P&G HYGIENE & HEALTH CARE share price move in a day?

On a typical session P&G HYGIENE & HEALTH CARE moves 0.69% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.

When are P&G HYGIENE & HEALTH CARE's next results?

Financial Results on Thu, 12 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track P&G HYGIENE & HEALTH CARE's announcements?

Every NSE and BSE filing by P&G HYGIENE & HEALTH CARE appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.